Literature DB >> 26401642

Dollars and Discomfort: What Will People Be Willing to Give for Better Blood Pressure Assessment?

Anthony J Viera1, Laura Tuttle1, Jennifer Zeng1.   

Abstract

Recently, the US Preventive Services Task Force issued a draft recommendation to utilize 24-hour ambulatory blood pressure (BP) monitoring (ABPM) to confirm the diagnosis of hypertension after screening. However, ABPM can be inconvenient and has some adverse effects such as pain and bruising from the repeated cuff inflations. In this national survey, we asked adults 30 years and older how much physical discomfort they would be willing to undergo to have the most accurate test available for evaluating possible high BP. We also asked how much they would be willing to pay to have the test. Among 1010 respondents, 95% of participants indicated willingness to undergo at least mild physical discomfort. The median amount people would be willing to pay was $25. These findings suggest that people are willing to undergo a bit of discomfort, and even pay a small amount, for the benefit of accurate BP assessment.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26401642      PMCID: PMC8031994          DOI: 10.1111/jch.12680

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  5 in total

1.  Management of hypertension: summary of NICE guidance.

Authors:  Taryn Krause; Kate Lovibond; Mark Caulfield; Terry McCormack; Bryan Williams
Journal:  BMJ       Date:  2011-08-25

Review 2.  Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Margaret A Piper; Corinne V Evans; Brittany U Burda; Karen L Margolis; Elizabeth O'Connor; Evelyn P Whitlock
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

3.  Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study.

Authors:  Kate Lovibond; Sue Jowett; Pelham Barton; Mark Caulfield; Carl Heneghan; F D Richard Hobbs; James Hodgkinson; Jonathan Mant; Una Martin; Bryan Williams; David Wonderling; Richard J McManus
Journal:  Lancet       Date:  2011-08-23       Impact factor: 79.321

4.  Tolerability of the Oscar 2 ambulatory blood pressure monitor among research participants: a cross-sectional repeated measures study.

Authors:  Anthony J Viera; Kara Lingley; Alan L Hinderliter
Journal:  BMC Med Res Methodol       Date:  2011-04-27       Impact factor: 4.615

5.  Dollars and Discomfort: What Will People Be Willing to Give for Better Blood Pressure Assessment?

Authors:  Anthony J Viera; Laura Tuttle; Jennifer Zeng
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-24       Impact factor: 3.738

  5 in total
  4 in total

1.  Evaluating different criteria for defining a complete ambulatory blood pressure monitoring recording: data from the Jackson Heart Study.

Authors:  Samantha G Bromfield; John N Booth; Matthew S Loop; Joseph E Schwartz; Samantha R Seals; Stephen J Thomas; Yuan-I Min; Gbenga Ogedegbe; Daichi Shimbo; Paul Muntner
Journal:  Blood Press Monit       Date:  2018-04       Impact factor: 1.444

Review 2.  Multi-Site Photoplethysmography Technology for Blood Pressure Assessment: Challenges and Recommendations.

Authors:  Gabriel Chan; Rachel Cooper; Manish Hosanee; Kaylie Welykholowa; Panayiotis A Kyriacou; Dingchang Zheng; John Allen; Derek Abbott; Nigel H Lovell; Richard Fletcher; Mohamed Elgendi
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

3.  Dollars and Discomfort: What Will People Be Willing to Give for Better Blood Pressure Assessment?

Authors:  Anthony J Viera; Laura Tuttle; Jennifer Zeng
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-24       Impact factor: 3.738

4.  Validation of a wearable cuff-less wristwatch-type blood pressure monitoring device.

Authors:  Joon Ho Moon; Myung-Kyun Kang; Chang-Eun Choi; Jeonghee Min; Hae-Young Lee; Soo Lim
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.